| Literature DB >> 25451228 |
Ji-Hae Lee1, Ji-Yeon Lee1, Seung Bae Rho2, Jong-Soon Choi3, Dong-Gi Lee3, Sungwhan An4, Taejeong Oh4, Don-Chan Choi5, Seung-Hoon Lee6.
Abstract
Secretory clusterin (sCLU), an anti-apoptotic protein, is overexpressed in many tumors and enhances tumorigenesis and chemo-resistance. However, the regulation mechanism controlling the sCLU maturation process or activity remains undetermined. In this study, we found PACAP as a negative regulator of CLU. Overexpression of the PACAP gene in cervical cancer cell lines lacking PACAP expression significantly inhibited cell growth and induced apoptosis. We further demonstrated that interaction of PACAP with CLU significantly downregulated CLU expression and secretion, inhibited the Akt-Raf-ERK pathway, and suppressed the growth of human tumor xenografts in nude mice. This novel inhibitory function of PACAP may be applicable for developing novel molecular therapies for tumors with increased sCLU expression.Entities:
Keywords: Akt/Raf/ERK pathway; Apoptosis; Cervical cancer; Clusterin; Pituitary adenylate cyclase-activating polypeptide
Mesh:
Substances:
Year: 2014 PMID: 25451228 DOI: 10.1016/j.febslet.2014.11.004
Source DB: PubMed Journal: FEBS Lett ISSN: 0014-5793 Impact factor: 4.124